Monogenic and polygenic determinants of sarcoma risk: an international genetic studyMandy L. Ballinger, David M. Thomas, Robert G. Maki et al.|The Lancet Oncology|2016Cited by 213
The tankyrase‐specific inhibitor <scp>JW</scp>74 affects cell cycle progression and induces apoptosis and differentiation in osteosarcoma cell linesEva W. Stratford, Ola Myklebost|Cancer Medicine|2013Cited by 61
Preclinical Evaluation of the Pan-FGFR Inhibitor LY2874455 in FRS2-Amplified LiposarcomaRobert Hanes, Ola Myklebost|Cells|2019Cited by 20
The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibitionIrantzu Anzar, Trevor Clancy, Brandon Malone et al.|Frontiers in Immunology|2023Cited by 12
The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibitionIrantzu Anzar, Trevor Clancy, Brandon Malone et al.|medRxiv|2023Cited by 0